Oxymorphone: a review - PubMed

Review

Oxymorphone: a review

Eric Prommer. Support Care Cancer. 2006 Feb.

Abstract

Oxymorphone (oxymorphone hydrochloride) (14-hydroxy-dihydromorphinone), a semisynthetic mu-opioid agonist, was first approved by the US Food and Drug Administration in 1959. Oxymorphone is considered a more potent opioid than its parent compound, morphine. Recently, an immediate-release and long-acting oral formulation of this drug was developed that makes oxymorphone a new option in treating moderate to severe pain. This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain.

Similar articles

• Oral oxymorphone (Opana).

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2007 Jan 1;49(1251):3-4. Med Lett Drugs Ther. 2007. PMID: 17179898 No abstract available.

• Oral extended-release oxymorphone: a new choice for chronic pain relief.

  Matsumoto AK. Matsumoto AK. Expert Opin Pharmacother. 2007 Jul;8(10):1515-27. doi: 10.1517/14656566.8.10.1515. Expert Opin Pharmacother. 2007. PMID: 17661733 Review.

• Clinical applications of oxymorphone.

  Vadivelu N, Maria M, Jolly S, Rosenbloom J, Prasad A, Kaye AD. Vadivelu N, et al. J Opioid Manag. 2013 Nov-Dec;9(6):439-52. doi: 10.5055/jom.2013.0186. J Opioid Manag. 2013. PMID: 24481932 Review.

• Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review.

  Sloan PA, Barkin RL. Sloan PA, et al. J Opioid Manag. 2008 May-Jun;4(3):131-44. doi: 10.5055/jom.2008.0018. J Opioid Manag. 2008. PMID: 18717508 Review.

• Use of oral oxymorphone in the elderly.

  Guay DR. Guay DR. Consult Pharm. 2007 May;22(5):417-30. doi: 10.4140/tcp.n.2007.417. Consult Pharm. 2007. PMID: 17658959 Review.

Cited by

• Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.

  Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Park TW, et al. BMJ. 2015 Jun 10;350:h2698. doi: 10.1136/bmj.h2698. BMJ. 2015. PMID: 26063215 Free PMC article.

• Cancer Pain Management: Opioid Analgesics, Part 2.

  Wickham RJ. Wickham RJ. J Adv Pract Oncol. 2017 Sep-Oct;8(6):588-607. Epub 2017 Sep 1. J Adv Pract Oncol. 2017. PMID: 30310721 Free PMC article. Review.

• Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone.

  Grönlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Olkkola KT, Laine K. Grönlund J, et al. Br J Clin Pharmacol. 2010 Jul;70(1):78-87. doi: 10.1111/j.1365-2125.2010.03653.x. Br J Clin Pharmacol. 2010. PMID: 20642550 Free PMC article. Clinical Trial.

• Opioid dose and risk of suicide.

  Ilgen MA, Bohnert ASB, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Ilgen MA, et al. Pain. 2016 May;157(5):1079-1084. doi: 10.1097/j.pain.0000000000000484. Pain. 2016. PMID: 26761386 Free PMC article.

• Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.

  Smith LJ, Kukanich BK, Krugner-Higby LA, Schmidt BH, Heath TD. Smith LJ, et al. Vet Anaesth Analg. 2013 Sep;40(5):537-45. doi: 10.1111/vaa.12042. Epub 2013 Apr 20. Vet Anaesth Analg. 2013. PMID: 23601353 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program